Federal officials are now confronting another challenge for the uptake of a potential coronavirus vaccine – patient warehousing – along with waning public confidence in product safety and efficacy.
Hesitancy to take the first coronavirus vaccines because of unclear safety or efficacy and political influence is already pervasive in...







